VivoSim Labs Inc
VIVS
NASDAQ
Biotechnology
$0.32
USD
-0.01 (-1.71%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $3.50M
Volume 1.5M
Revenue
$131,000
TTM
— YoY
Gross Margin
100%
TTM
— YoY
Net Income
$-13.84M
TTM
— YoY
Operating Cash Flow
$-10.83M
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2026 | Q2 2026 | Q3 2026 | Q4 2026 |
|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 2.0 | 1.7 | 1.6 | 2.1 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 3.0 | 2.7 | 2.8 | 3.2 |
Operating Income | -2.9 | -2.6 | -2.8 | -3.2 |
EBITDA | -2.9 | -2.6 | -2.7 | -3.1 |
Other Income / Expense | 0.0 | 0.0 | 0.0 | -2.6 |
Total Other Income / Expense | 0.1 | 0.1 | 0.1 | -2.6 |
Income Before Income Taxes | -2.8 | -2.5 | -2.7 | -5.8 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -2.8 | -2.5 | -2.7 | -5.8 |
Consolidated Net Income / Loss | -2.8 | -2.5 | -2.7 | -5.8 |
Net Income Attributable to Common Shareholders | -2.8 | -2.5 | -2.7 | -5.8 |
Basic EPS | -$1.14 | -$0.98 | -$1.03 | -$2.19 |
Diluted EPS | -$1.14 | -$0.98 | -$1.03 | -$2.19 |
Basic Shares Outstanding | 2.5M | 2.6M | 2.6M | 2.6M |
Diluted Shares Outstanding | 2.5M | 2.6M | 2.6M | 2.6M |